V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310011307 | 310008409 | null | 69.8 | Palliative (P) | 2019-03-07 | 2019-03-08 | CETUXIMAB | 2 | N | 310003601 | DABRAFENIB |
| 310011308 | 310005466 | 1.82 | 81.5 | Palliative (P) | 2018-01-15 | 2018-07-12 | Bortezomib + Cyclophos + Dex | N | N | 310003672 | IFOSFAMIDE + PACLITAXEL |
| 310011309 | 310005471 | 1.69 | 63.1 | Palliative (P) | 2017-06-03 | 2017-07-12 | CHLVPP | N | N | 310003732 | METHOTREXATE HIGH DOSE |
| 310011310 | 310005475 | 1.63 | 50.6 | Curative (C) | 2018-12-30 | 2019-01-23 | IVE + METHOTREXATE | N | null | 310003761 | TRABECTEDIN |
| 310011311 | 310005480 | 1.68 | null | Palliative (P) | 2015-07-02 | 2015-07-23 | CETUXIMAB | N | N | 310003808 | BCG |
| 310011312 | 310005483 | 1.8 | null | Palliative (P) | 2014-08-22 | 2014-09-13 | Carboplatin + Pemetrexed | 02 | N | 310004066 | RCEOP |
| 310011313 | 310005488 | 1.81 | null | Disease modification (D) | 2014-07-26 | 2014-08-02 | Vemurafenib | N | N | 310005975 | DACARBAZINE |
| 310011314 | 310005493 | 1.62 | null | Curative (C) | 2016-10-30 | 2016-07-11 | CETUXIMAB | N | N | 310006698 | CHOEP |
| 310011315 | 310005498 | 1.73 | 23.6 | Curative (C) | 2016-02-05 | 2016-02-25 | Cetuximab 7 day (>Cycle 2) | 02 | null | 310007286 | FLUOROURACIL |
| 310011316 | 310005502 | 1.83 | 61 | Palliative (P) | 2018-11-24 | 2019-01-08 | Carboplatin + Docetaxel | N | N | 310007470 | VINBLASTINE |
| 310011317 | 310011599 | null | null | Neo-adjuvant (N) | 2014-05-12 | 2014-06-18 | Doxorubicin 75mg/m2 | 2 | N | 310007558 | AZACITIDINE |
| 310011318 | 310005505 | 1.74 | null | Palliative (P) | 2016-06-06 | 2016-12-11 | DOXORUBICIN | N | N | 310007855 | IFOSFAMIDE |
| 310011319 | 310005519 | 1.54 | 68.9 | null | 2016-03-11 | 2016-03-11 | Doxorubicin + Ifosfamide | N | null | 310011231 | METHOTREXATE HD + VINCRISTINE |
| 310011320 | 310005523 | null | 65 | Neo-adjuvant (N) | 2015-08-26 | 2017-04-12 | Olaparib | N | null | 310011253 | ECX |
| 310011321 | 310010006 | 1.63 | 78.4 | Palliative (P) | 2017-01-19 | 2017-03-27 | UKALL XII Intensification | Y | null | 310012353 | ECX |
| 310011322 | 310008453 | 1.68 | null | Adjuvant (A) | 2019-01-28 | 2019-07-02 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | N | N | 310013706 | OXALIPLATIN + MDG |
| 310011323 | 310005560 | 1.52 | null | Adjuvant (A) | 2018-04-18 | 2018-08-06 | RUXOLITINIB | N | N | 310018395 | UKALL2014 |
| 310011324 | 310010015 | 1.62 | 54.1 | Palliative (P) | 2019-04-29 | 2019-04-30 | RUXOLITINIB | N | null | 310020027 | TRABECTEDIN |
| 310011325 | 310008471 | 1.53 | 59.75 | Palliative (P) | 2017-06-23 | 2017-07-28 | CVP R + ETOPOSIDE | N | null | 310020428 | ICE |
| 310011326 | 310011338 | 1.59 | 6.82 | Palliative (P) | 2016-10-12 | 2017-02-22 | CISPLATIN + ETOPOSIDE | 2 | null | 310020916 | BENDAMUSTINE |
| 310011327 | 310008473 | null | 74.6 | Palliative (P) | 2018-06-15 | 2018-06-15 | Oxaliplatin + Modified de Gramont | 2 | N | 310021471 | CISPLATIN + DACTINOMYCIN + ETOPOSIDE + METHOTREXATE |
| 310011328 | 310005580 | 0 | null | Palliative (P) | 2015-03-20 | 2015-02-20 | UKALL14- Ph 2 Induction | null | null | 310021589 | ICON TRIAL |
| 310011329 | 310011760 | 1.8 | null | Palliative (P) | 2017-01-08 | 2017-10-30 | Capecitabine + Oxaliplatin 21day | N | N | 310022102 | CETUXIMAB |
| 310011330 | 310005592 | 1.62 | 54.1 | Adjuvant (A) | 2015-12-18 | 2016-03-10 | CISPLATIN + FLUOROURACIL | null | null | 310022562 | BORTEZOMIB |
| 310011331 | 310005595 | null | 62.1 | Palliative (P) | 2015-03-24 | 2015-03-24 | REGORAFENIB | 02 | N | 310022639 | BORTEZOMIB |
| 310011332 | 310005598 | 1.78 | 89.6 | Palliative (P) | 2015-06-12 | 2015-09-30 | Vemurafenib | 2 | N | 310022751 | SELPAC TRIAL |
| 310011333 | 310005607 | 1.59 | 0 | Palliative (P) | 2019-07-18 | 2019-07-18 | BCG Intravesical | N | N | 310022924 | AZACITIDINE |
| 310011334 | 310005611 | 1.71 | 86.6 | Curative (C) | 2020-05-26 | 2020-06-07 | CHOEP | 02 | N | 310023035 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 310011335 | 310011936 | null | 107 | Palliative (P) | 2017-07-16 | 2017-12-23 | CHOEP | N | N | 310023406 | OCTOPUS TRIAL |
| 310011336 | 310008498 | 1.84 | 86.7 | Palliative (P) | 2015-09-01 | 2016-05-03 | Erlotinib | N | null | 310023408 | TRIPLE INTRATHECAL |
| 310011337 | 310005623 | 1.76 | 79.4 | Palliative (P) | 2017-09-01 | 2017-09-25 | CISPLATIN + ETOPOSIDE + PACLITAXEL | 02 | N | 310023655 | NIVOLUMAB |
| 310011338 | 310008507 | 1.76 | 81 | Adjuvant (A) | 2018-01-19 | 2018-05-26 | CRIZOTINIB | 02 | N | 310024263 | ENZALUTAMIDE |
| 310011339 | 310005643 | null | 76 | Palliative (P) | 2014-05-06 | 2014-05-12 | CHLVPP | 2 | N | 310024340 | DOXORUBICIN |
| 310011340 | 310005648 | 1.75 | 0 | Palliative (P) | 2017-07-03 | 2018-09-06 | TEMOZOLOMIDE | N | N | 310024565 | DOXORUBICIN + OLARATUMAB |
| 310011341 | 310005660 | 0 | 83 | Palliative (P) | 2015-01-20 | 2015-01-20 | DABRAFENIB + TRAMETINIB | 2 | N | 310025101 | TRABECTEDIN |
| 310011342 | 310011953 | null | 66.4 | Palliative (P) | 2017-11-22 | 2017-11-25 | CAV | N | N | 310025295 | CAPECITABINE + OXALIPLATIN |
| 310011343 | 310005664 | 1.72 | 78 | Palliative (P) | 2017-06-11 | 2017-10-08 | DABRAFENIB + TRAMETINIB | Y | N | 310025400 | INCA TRIAL |
| 310011344 | 310008523 | 1.57 | 54.4 | Palliative (P) | 2018-06-20 | 2018-06-27 | MITOMYCIN | 2 | N | 310025467 | OXALIPLATIN + MDG |
| 310011345 | 310010046 | 1.85 | 62 | null | 2018-12-31 | 2019-04-24 | Topotecan (oral) | 02 | N | 310025486 | CARMUSTINE + THIOTEPA |
| 310011346 | 310010048 | null | 68.7 | Not known (9) | 2011-03-12 | 2015-05-18 | DABRAFENIB + TRAMETINIB | N | N | 310025707 | ATG |
| 310011347 | 310005681 | 1.59 | null | Curative (C) | null | 2014-11-20 | Cytarabine intrathecal | N | N | 310025747 | BCG |
| 310011348 | 310005688 | 1.54 | 48 | Palliative (P) | 2020-03-03 | 2020-04-29 | Cytarabine intrathecal | N | N | 310002637 | HYDROXYCARBAMIDE |
| 310011349 | 310005694 | 1.54 | 53.6 | Palliative (P) | 2017-03-28 | 2017-05-22 | Trabectedin | null | null | 310003715 | CTD |
| 310011350 | 310005710 | 1.79 | 67.3 | Curative (C) | null | 2018-02-03 | CYCLOPHOSPHAMIDE + ETOPOSIDE | N | N | 310016083 | DABRAFENIB + TRAMETINIB |
| 310011351 | 310005725 | null | 76.6 | Palliative (P) | 2019-02-26 | 2019-03-26 | CHLVPP | N | null | 310024427 | CISPLATIN + FLUOROURACIL |
| 310011352 | 310005731 | 1.78 | 75 | Palliative (P) | null | 2019-02-12 | DOXORUBICIN | 02 | null | 310024445 | DACARBAZINE |
| 310011353 | 310010063 | null | 74.6 | Palliative (P) | 2020-08-18 | 2020-08-27 | TRASTUZUMAB | N | null | 310002808 | TOPOTECAN |
| 310011354 | 310008554 | 1.73 | 61 | Palliative (P) | 2018-09-26 | 2018-12-05 | Irinotecan + Modified De Gramont | N | N | 310003015 | DABRAFENIB + TRAMETINIB |
| 310011355 | 310008555 | 1.73 | 91.4 | null | 2017-10-30 | 2017-10-30 | CARMUSTINE + THIOTEPA | N | N | 310003166 | BENDAMUSTINE |
| 310011356 | 310002714 | 1.65 | 61.5 | Palliative (P) | 2018-03-15 | 2018-04-12 | Carboplatin AUC 6 - 10 | 02 | N | 310003972 | CARBOPLATIN |